tiprankstipranks
Advertisement
Advertisement

HK:9995 Stock Latest News

RemeGen Commits RMB1.43 Billion of Idle Funds to Wealth Management Products
Company AnnouncementsRemeGen Commits RMB1.43 Billion of Idle Funds to Wealth Management Products
17h ago
RemeGen Issues Unaudited 2026 First-Quarter Report and Cautions Investors
PremiumCompany Announcements
RemeGen Issues Unaudited 2026 First-Quarter Report and Cautions Investors
16d ago
RemeGen Sets Board Meeting to Approve First-Quarter 2026 Results
PremiumCompany Announcements
RemeGen Sets Board Meeting to Approve First-Quarter 2026 Results
28d ago
RemeGen Receives US$650 Million Upfront from AbbVie for RC148 Global Rights
PremiumCompany Announcements
RemeGen Receives US$650 Million Upfront from AbbVie for RC148 Global Rights
29d ago
RemeGen Wins Fifth China Approval for Flagship ADC in Urothelial Cancer
PremiumCompany Announcements
RemeGen Wins Fifth China Approval for Flagship ADC in Urothelial Cancer
1M ago
RemeGen Wins NMPA Nod to Start Clinical Trial of Bispecific ADC RC288
PremiumCompany AnnouncementsRemeGen Wins NMPA Nod to Start Clinical Trial of Bispecific ADC RC288
1M ago
RemeGen Boosts 2025 Revenue as Telitacicept Wins New Approvals and NRDL Access
Premium
Company Announcements
RemeGen Boosts 2025 Revenue as Telitacicept Wins New Approvals and NRDL Access
2M ago
RemeGen Wins Fourth NMPA Approval for Disitamab Vedotin in HER2-Low Breast Cancer
Premium
Company Announcements
RemeGen Wins Fourth NMPA Approval for Disitamab Vedotin in HER2-Low Breast Cancer
2M ago
RemeGen Schedules March 27 Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
RemeGen Schedules March 27 Board Meeting to Approve 2025 Annual Results
2M ago
RemeGen Swings to Profit on Strong 2025 Revenue Growth
PremiumCompany Announcements
RemeGen Swings to Profit on Strong 2025 Revenue Growth
3M ago
RemeGen Forecasts 2025 Profit Turnaround on Surging Drug Sales and Global Licensing Deal
PremiumCompany Announcements
RemeGen Forecasts 2025 Profit Turnaround on Surging Drug Sales and Global Licensing Deal
3M ago
RemeGen Completes RMB20 Million A-Share Buyback for Future Equity Incentives
PremiumCompany Announcements
RemeGen Completes RMB20 Million A-Share Buyback for Future Equity Incentives
4M ago
RemeGen Raises Share Buyback Price Cap to Enable A‑Share Repurchase Plan
PremiumCompany AnnouncementsRemeGen Raises Share Buyback Price Cap to Enable A‑Share Repurchase Plan
4M ago
RemeGen Signs Up to US$5.6 Billion Global Licensing Deal with AbbVie for Cancer Drug RC148
Premium
Company Announcements
RemeGen Signs Up to US$5.6 Billion Global Licensing Deal with AbbVie for Cancer Drug RC148
4M ago
RemeGen Co., Ltd. Announces A Share Repurchase Plan to Boost Employee Incentives
Premium
Company Announcements
RemeGen Co., Ltd. Announces A Share Repurchase Plan to Boost Employee Incentives
5M ago
RemeGen Co., Ltd. Approves Key Resolutions at 2025 EGM
PremiumCompany Announcements
RemeGen Co., Ltd. Approves Key Resolutions at 2025 EGM
5M ago
9995
RemeGen Co., Ltd. Announces 2025 Third Extraordinary General Meeting
PremiumCompany Announcements
RemeGen Co., Ltd. Announces 2025 Third Extraordinary General Meeting
6M ago
9995
RemeGen Co., Ltd. Engages in Strategic Wealth Management Transaction
PremiumCompany Announcements
RemeGen Co., Ltd. Engages in Strategic Wealth Management Transaction
6M ago
9995
RemeGen Co., Ltd. Releases 2025 Q3 Unaudited Financial Report
PremiumCompany Announcements
RemeGen Co., Ltd. Releases 2025 Q3 Unaudited Financial Report
7M ago
9995
RemeGen Co., Ltd. Renews Key Connected Transactions and Adjusts Leasing Agreements
PremiumCompany AnnouncementsRemeGen Co., Ltd. Renews Key Connected Transactions and Adjusts Leasing Agreements
7M ago
9995
RemeGen Co., Ltd. Schedules Board Meeting to Review Q3 Results
Premium
Company Announcements
RemeGen Co., Ltd. Schedules Board Meeting to Review Q3 Results
7M ago
9995
RemeGen Co., Ltd. Engages in Strategic Cash Management with SPDB Wealth Products
Premium
Company Announcements
RemeGen Co., Ltd. Engages in Strategic Cash Management with SPDB Wealth Products
7M ago
9995

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >